California voters say yes to restrictions around 340B spending

While the JP Mor­gan Health­care Con­fer­ence was full of voic­es of mea­sured op­ti­mism, root­ing for the mar­ket to bounce back in 2024, one long­time biotech

Japan-based Seik­a­gaku will face an FDA ad­vi­so­ry com­mit­tee on Fri­day, with the agency rais­ing con­cerns ahead of the meet­ing re­gard­ing the ef­fi­ca­cy of its con­do­liase

Roche’s M&A strat­e­gy in the com­ing year re­volves around de­risked mech­a­nisms and high un­met needs, CEO Thomas Schi­neck­er said Thurs­day. And fur­ther deal­mak­ing over as­sets